Ajooni Biotech Limited Stock Current Valuation
| AJOONI Stock | 7.79 0.37 4.99% |
Valuation analysis of Ajooni Biotech helps investors to measure Ajooni Biotech's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, Ajooni Biotech's Cash is projected to increase significantly based on the last few years of reporting. The current year's Cash And Short Term Investments is expected to grow to about 7.1 M, whereas Free Cash Flow is projected to grow to (90.8 M). Fundamental drivers impacting Ajooni Biotech's valuation include:
Price Book 1.7264 | Enterprise Value 754.7 M | Enterprise Value Ebitda 17.0787 | Price Sales 0.9132 | Trailing PE 35.4091 |
Overvalued
Today
Please note that Ajooni Biotech's price fluctuation is slightly risky at this time. Calculation of the real value of Ajooni Biotech is based on 3 months time horizon. Increasing Ajooni Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ajooni Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ajooni Stock. However, Ajooni Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.79 | Real 6.76 | Hype 7.42 | Naive 7.51 |
The real value of Ajooni Stock, also known as its intrinsic value, is the underlying worth of Ajooni Biotech Company, which is reflected in its stock price. It is based on Ajooni Biotech's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ajooni Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ajooni Biotech Limited helps investors to forecast how Ajooni stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ajooni Biotech more accurately as focusing exclusively on Ajooni Biotech's fundamentals will not take into account other important factors: Ajooni Biotech Limited Company Current Valuation Analysis
Ajooni Biotech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Ajooni Biotech Current Valuation | 754.71 M |
Most of Ajooni Biotech's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ajooni Biotech Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Ajooni Biotech Limited has a Current Valuation of 754.71 M. This is 96.11% lower than that of the Food Products sector and 92.39% lower than that of the Consumer Staples industry. The current valuation for all India stocks is 95.46% higher than that of the company.
Ajooni Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ajooni Biotech's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ajooni Biotech could also be used in its relative valuation, which is a method of valuing Ajooni Biotech by comparing valuation metrics of similar companies.Ajooni Biotech is currently under evaluation in current valuation category among its peers.
Ajooni Fundamentals
| Return On Equity | 0.0354 | ||||
| Return On Asset | 0.0139 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 754.71 M | ||||
| Shares Outstanding | 99.37 M | ||||
| Price To Book | 1.73 X | ||||
| Price To Sales | 0.91 X | ||||
| Revenue | 800.01 M | ||||
| Gross Profit | 87.45 M | ||||
| EBITDA | 44.27 M | ||||
| Net Income | 21.61 M | ||||
| Total Debt | 21.68 M | ||||
| Book Value Per Share | 4.88 X | ||||
| Cash Flow From Operations | (39.52 M) | ||||
| Earnings Per Share | 0.22 X | ||||
| Number Of Employees | 109 | ||||
| Beta | 1.17 | ||||
| Market Capitalization | 774.1 M | ||||
| Total Asset | 475.2 M | ||||
| Retained Earnings | 86.91 M | ||||
| Working Capital | 194.62 M | ||||
| Net Asset | 475.2 M |
About Ajooni Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ajooni Biotech Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ajooni Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ajooni Biotech Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ajooni Stock
Ajooni Biotech financial ratios help investors to determine whether Ajooni Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ajooni with respect to the benefits of owning Ajooni Biotech security.